pmc logo imageJournal ListSearchpmc logo image
Logo of envhperEHP WebsiteAbout EHPPublicationsNews By TopicAuthorsSubscribePressEmail AlertsSearch EHP
Environ Health Perspect. 2000 May; 108(Suppl 2): 323–334.
PMCID: PMC1637754
Research Article
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.
H A Barton and H J Clewell, 3rd
K.S. Crump Group, Inc., ICF Consulting, Research Triangle Park, NC, USA. habarton@alum.mit.edu
Abstract
Alternatives for developing chronic exposure limits for noncancer effects of trichloroethylene (TCE) were evaluated. These alternatives were organized within a framework for dose-response assessment--exposure:dosimetry (pharmacokinetics):mode of action (pharmacodynamics): response. This framework provides a consistent structure within which to make scientific judgments about available information, its interpretation, and use. These judgments occur in the selection of critical studies, internal dose metrics, pharmacokinetic models, approaches for interspecies extrapolation of pharmacodynamics, and uncertainty factors. Potentially limiting end points included developmental eye malformations, liver effects, immunotoxicity, and kidney toxicity from oral exposure and neurological, liver, and kidney effects by inhalation. Each end point was evaluated quantitatively using several methods. Default analyses used the traditional no-observed adverse effect level divided by uncertainty factors and the benchmark dose divided by uncertainty factors methods. Subsequently, mode-of-action and pharmacokinetic information were incorporated. Internal dose metrics were estimated using a physiologically based pharmacokinetic (PBPK) model for TCE and its major metabolites. This approach was notably useful with neurological and kidney toxicities. The human PBPK model provided estimates of human exposure doses for the internal dose metrics. Pharmacodynamic data or default assumptions were used for interspecies extrapolation. For liver and neurological effects, humans appear no more sensitive than rodents when internal dose metrics were considered. Therefore, the interspecies uncertainty factor was reduced, illustrating that uncertainty factors are a semiquantitative approach fitting into the organizational framework. Incorporation of pharmacokinetics and pharmacodynamics can result in values that differ significantly from those obtained with the default methods.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Barton, HA; Das, S. Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene. Regul Toxicol Pharmacol. 1996 Dec;24(3):269–285. [PubMed]
  • Davidson, IW; Beliles, RP. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev. 1991;23(5-6):493–599. [PubMed]
  • Gist, GL; Burg, JR. Trichloroethylene--a review of the literature from a health effects perspective. Toxicol Ind Health. 1995 11(3):253–307.May–Jun; [PubMed]
  • Dourson, ML; Stara, JF. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol. 1983 Sep;3(3):224–238. [PubMed]
  • Renwick, AG. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit Contam. 1993 10(3):275–305.May–Jun; [PubMed]
  • Crump, KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol. 1984 Oct;4(5):854–871. [PubMed]
  • Barnes, DG; Daston, GP; Evans, JS; Jarabek, AM; Kavlock, RJ; Kimmel, CA; Park, C; Spitzer, HL. Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul Toxicol Pharmacol. 1995 Apr;21(2):296–306. [PubMed]
  • Clewell, HJ, 3rd; Gentry, PR; Gearhart, JM. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment. J Toxicol Environ Health. 1997 Dec 26;52(6):475–515. [PubMed]
  • Tucker, AN; Sanders, VM; Barnes, DW; Bradshaw, TJ; White, KL, Jr; Sain, LE; Borzelleca, JF; Munson, AE. Toxicology of trichloroethylene in the mouse. Toxicol Appl Pharmacol. 1982 Mar 15;62(3):351–357. [PubMed]
  • Sanders, VM; Tucker, AN; White, KL, Jr; Kauffmann, BM; Hallett, P; Carchman, RA; Borzelleca, JF; Munson, AE. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol Appl Pharmacol. 1982 Mar 15;62(3):358–368. [PubMed]
  • Feldman, RG; Chirico-Post, J; Proctor, SP. Blink reflex latency after exposure to trichloroethylene in well water. Arch Environ Health. 1988 43(2):143–148.Mar–Apr; [PubMed]
  • Kilburn, KH; Warshaw, RH. Effects on neurobehavioral performance of chronic exposure to chemically contaminated well water. Toxicol Ind Health. 1993 9(3):391–404.May–Jun; [PubMed]
  • Henschler, D; Elsässer, H; Romen, W; Eder, E. Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, in mice. J Cancer Res Clin Oncol. 1984;107(3):149–156. [PubMed]
  • Barret, L; Torch, S; Leray, CL; Sarliève, L; Saxod, R. Morphometric and biochemical studies in trigeminal nerve of rat after trichloroethylene or dichloroacetylene oral administration. Neurotoxicology. 1992 13(3):601–614.Fall; [PubMed]
  • Narotsky, MG; Kavlock, RJ. A multidisciplinary approach to toxicological screening: II. Developmental toxicity. J Toxicol Environ Health. 1995 Jun;45(2):145–171. [PubMed]
  • Moser, VC; Cheek, BM; MacPhail, RC. A multidisciplinary approach to toxicological screening: III. Neurobehavioral toxicity. J Toxicol Environ Health. 1995 Jun;45(2):173–210. [PubMed]
  • Taylor, DH; Lagory, KE; Zaccaro, DJ; Pfohl, RJ; Laurie, RD. Effect of trichloroethylene on the exploratory and locomotor activity of rats exposed during development. Sci Total Environ. 1985 Dec;47:415–420. [PubMed]
  • Isaacson, LG; Spohler, SA; Taylor, DH. Trichloroethylene affects learning and decreases myelin in the rat hippocampus. Neurotoxicol Teratol. 1990 12(4):375–381.Jul–Aug; [PubMed]
  • Luster, MI; Portier, C; Pait, DG; White, KL, Jr; Gennings, C; Munson, AE; Rosenthal, GJ. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol. 1992 Feb;18(2):200–210. [PubMed]
  • Luster, MI; Portier, C; Pait, DG; Rosenthal, GJ; Germolec, DR; Corsini, E; Blaylock, BL; Pollock, P; Kouchi, Y; Craig, W, et al. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol. 1993 Jul;21(1):71–82. [PubMed]
  • Kauffmann, BM; White, KL, Jr; Sanders, VM; Douglas, KA; Sain, LE; Borzelleca, JF; Munson, AE. Humoral and cell-mediated immune status in mice exposed to chloral hydrate. Environ Health Perspect. 1982 Apr;44:147–151. [PubMed]
  • Cosby, NC; Dukelow, WR. Toxicology of maternally ingested trichloroethylene (TCE) on embryonal and fetal development in mice and of TCE metabolites on in vitro fertilization. Fundam Appl Toxicol. 1992 Aug;19(2):268–274. [PubMed]
  • Dawson, BV; Johnson, PD; Goldberg, SJ; Ulreich, JB. Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water. J Am Coll Cardiol. 1993 May;21(6):1466–1472. [PubMed]
  • Zenick, H; Blackburn, K; Hope, E; Richdale, N; Smith, MK. Effects of trichloroethylene exposure on male reproductive function in rats. Toxicology. 1984 Jun;31(3-4):237–250. [PubMed]
  • Manson, JM; Murphy, M; Richdale, N; Smith, MK. Effects of oral exposure to trichloroethylene on female reproductive function. Toxicology. 1984 Sep 14;32(3):229–242. [PubMed]
  • Narotsky, MG; Weller, EA; Chinchilli, VM; Kavlock, RJ. Nonadditive developmental toxicity in mixtures of trichloroethylene, Di(2-ethylhexyl) phthalate, and heptachlor in a 5 x 5 x 5 design. Fundam Appl Toxicol. 1995 Sep;27(2):203–216. [PubMed]
  • Smith, MK; Randall, JL; Read, EJ; Stober, JA. Teratogenic activity of trichloroacetic acid in the rat. Teratology. 1989 Nov;40(5):445–451. [PubMed]
  • Epstein, DL; Nolen, GA; Randall, JL; Christ, SA; Read, EJ; Stober, JA; Smith, MK. Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat. Teratology. 1992 Sep;46(3):225–235. [PubMed]
  • Smith, MK; Randall, JL; Read, EJ; Stober, JA. Developmental toxicity of dichloroacetate in the rat. Teratology. 1992 Sep;46(3):217–223. [PubMed]
  • Johnson, PD; Dawson, BV; Goldberg, SJ. Cardiac teratogenicity of trichloroethylene metabolites. J Am Coll Cardiol. 1998 Aug;32(2):540–545. [PubMed]
  • Johnson, PD; Dawson, BV; Goldberg, SJ. A review: trichloroethylene metabolites: potential cardiac teratogens. Environ Health Perspect. 1998 Aug;106 Suppl 4:995–999. [PubMed]
  • Berman, E; Schlicht, M; Moser, VC; MacPhail, RC. A multidisciplinary approach to toxicological screening: I. Systemic toxicity. J Toxicol Environ Health. 1995 Jun;45(2):127–143. [PubMed]
  • Stott, WT; Quast, JF; Watanabe, PG. The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicol Appl Pharmacol. 1982 Jan;62(1):137–151. [PubMed]
  • Borzelleca, JF; O'Hara, TM; Gennings, C; Granger, RH; Sheppard, MA; Condie, LW., Jr Interactions of water contaminants. I. Plasma enzyme activity and response surface methodology following gavage administration of CCl4 and CHCl3 or TCE singly and in combination in the rat. Fundam Appl Toxicol. 1990 Apr;14(3):477–490. [PubMed]
  • Buben, JA; O'Flaherty, EJ. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicol Appl Pharmacol. 1985 Mar 30;78(1):105–122. [PubMed]
  • Elcombe, CR. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol Suppl. 1985;8:6–17. [PubMed]
  • Elcombe, CR; Rose, MS; Pratt, IS. Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. Toxicol Appl Pharmacol. 1985 Jul;79(3):365–376. [PubMed]
  • Goel, SK; Rao, GS; Pandya, KP; Shanker, R. Trichloroethylene toxicity in mice: a biochemical, hematological and pathological assessment. Indian J Exp Biol. 1992 May;30(5):402–406. [PubMed]
  • Melnick, RL; Jameson, CW; Goehl, TJ; Maronpot, RR; Collins, BJ; Greenwell, A; Harrington, FW; Wilson, RE; Tomaszewski, KE; Agarwal, DK. Application of microencapsulation for toxicology studies. II. Toxicity of microencapsulated trichloroethylene in Fischer 344 rats. Fundam Appl Toxicol. 1987 May;8(4):432–442. [PubMed]
  • Merrick, BA; Robinson, M; Condie, LW. Differing hepatotoxicity and lethality after subacute trichloroethylene exposure in aqueous or corn oil gavage vehicles in B6C3F1 mice. J Appl Toxicol. 1989 Feb;9(1):15–21. [PubMed]
  • Maltoni, C; Lefemine, G; Cotti, G; Perino, G. Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice. Ann N Y Acad Sci. 1988;534:316–342. [PubMed]
  • Annau, Z. The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol. 1981 3(4):417–424.Winter; [PubMed]
  • Haglid, KG; Briving, C; Hansson, HA; Rosengren, L; Kjellstrand, P; Stavron, D; Swedin, U; Wronski, A. Trichloroethylene: long-lasting changes in the brain after rehabilitation. Neurotoxicology. 1981 Dec;2(4):659–673. [PubMed]
  • Kjellstrand, P; Edström, A; Bjerkemo, M; Holmquist, B. Effects of trichloroethylene inhalation on acid phosphatase in rodent brain. Toxicol Lett. 1982 Jan;10(1):1–5. [PubMed]
  • Kjellstrand, P; Kanje, M; Bjerkemo, M. Regeneration of the sciatic nerve in mice and rats exposed to trichloroethylene. Toxicol Lett. 1987 Sep;38(1-2):187–191. [PubMed]
  • Kulig, BM. The effects of chronic trichloroethylene exposure on neurobehavioral functioning in the rat. Neurotoxicol Teratol. 1987 9(2):171–178.Mar–Apr; [PubMed]
  • Savolainen, H; Pfäffli, P; Tengén, M; Vainio, H. Trichloroethylene and 1,1,1-trichloroethane: effects on brain and liver after five days intermittent inhalation. Arch Toxicol. 1977 Sep 28;38(3):229–237. [PubMed]
  • Westergren, I; Kjellstrand, P; Linder, LE; Johansson, BB. Reduction of brain specific gravity in mice prenatally exposed to trichloroethylene. Toxicol Lett. 1984 Nov;23(2):223–226. [PubMed]
  • GOLDBERG, ME; JOHNSON, HE; POZZANI, UC; SMYTH, HF., Jr BEHAVIOURAL RESPONSE OF RATS DURING INHALATION OF TRICHLORETHYLENE AND CARBON DISULPHIDE VAPOURS. Acta Pharmacol Toxicol (Copenh). 1964;21:36–44. [PubMed]
  • Kishi, R; Harabuchi, I; Ikeda, T; Katakura, Y; Miyake, H. Acute effects of trichloroethylene on blood concentrations and performance decrements in rats and their relevance to humans. Br J Ind Med. 1993 May;50(5):470–480. [PubMed]
  • Silverman, AP; Williams, H. Behaviour of rats exposed to trichloroethylene vapour. Br J Ind Med. 1975 Nov;32(4):308–315. [PubMed]
  • Blain, L; Lachapelle, P; Molotchnikoff, S. Electroretinal responses are modified by chronic exposure to trichloroethylene. Neurotoxicology. 1994 15(3):627–631.Fall; [PubMed]
  • Boyes, WK; Bushnell, PJ; Crofton, KM; Evans, M; Simmons, JE. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario. Environ Health Perspect. 2000 May;108 Suppl 2:317–322. [PubMed]
  • Arito, H; Takahashi, M; Ishikawa, T. Effect of subchronic inhalation exposure to low-level trichloroethylene on heart rate and wakefulness-sleep in freely moving rats. Sangyo Igaku. 1994 Jan;36(1):1–8. [PubMed]
  • Spirtas, R; Stewart, PA; Lee, JS; Marano, DE; Forbes, CD; Grauman, DJ; Pettigrew, HM; Blair, A; Hoover, RN; Cohen, JL. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br J Ind Med. 1991 Aug;48(8):515–530. [PubMed]
  • Aranyi, C; O'Shea, WJ; Graham, JA; Miller, FJ. The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam Appl Toxicol. 1986 May;6(4):713–720. [PubMed]
  • Hobara, T; Kobayashi, H; Higashihara, E; Kawamoto, T; Sakai, T. Acute effects of 1,1,1-trichloroethane, trichloroethylene, and toluene on the hematologic parameters in dogs. Arch Environ Contam Toxicol. 1984 Sep;13(5):589–593. [PubMed]
  • Windham, GC; Shusterman, D; Swan, SH; Fenster, L; Eskenazi, B. Exposure to organic solvents and adverse pregnancy outcome. Am J Ind Med. 1991;20(2):241–259. [PubMed]
  • Tola, S; Vilhunen, R; Järvinen, E; Korkala, ML. A cohort study on workers exposed to trichloroethylene. J Occup Med. 1980 Nov;22(11):737–740. [PubMed]
  • Corbett, TH; Cornell, RG; Endres, JL; Lieding, K. Birth defects among children of nurse-anesthetists. Anesthesiology. 1974 Oct;41(4):341–344. [PubMed]
  • Healy, TE; Poole, TR; Hopper, A. Rat fetal development and maternal exposure to trichloroethylene 100 p.p.m. Br J Anaesth. 1982 Mar;54(3):337–341. [PubMed]
  • Dorfmueller, MA; Henne, SP; York, RG; Bornschein, RL; Manson, JM. Evaluation of teratogenicity and behavioral toxicity with inhalation exposure of maternal rats to trichloroethylene. Toxicology. 1979 Oct;14(2):153–166. [PubMed]
  • Hardin, BD; Bond, GP; Sikov, MR; Andrew, FD; Beliles, RP; Niemeier, RW. Testing of selected workplace chemicals for teratogenic potential. Scand J Work Environ Health. 1981;7 Suppl 4:66–75. [PubMed]
  • Schwetz, BA; Leong, KJ; Gehring, PJ. The effect of maternally inhaled trichloroethylene, perchloroethylene, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats. Toxicol Appl Pharmacol. 1975 Apr;32(1):84–96. [PubMed]
  • Prendergast, JA; Jones, RA; Jenkins, LJ, Jr; Siegel, J. Effects on experimental animals of long-term inhalation of trichloroethylene, carbon tetrachloride, 1,1,1-trichloroethane, dichlorodifluoromethane, and 1,1-dichloroethylene. Toxicol Appl Pharmacol. 1967 Mar;10(2):270–289. [PubMed]
  • Odum, J; Foster, JR; Green, T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem Biol Interact. 1992 Aug 14;83(2):135–153. [PubMed]
  • Kimmerle, G; Eben, A. Metabolism, excretion and toxicology of trichloroethylene after inhalation. 1. Experimental exposure on rats. Arch Toxikol. 1973;30(2):115–126. [PubMed]
  • Kjellstrand, P; Kanje, M; Månsson, L; Bjerkemo, M; Mortensen, I; Lanke, J; Holmquist, B. Trichloroethylene: effects on body and organ weights in mice, rats and gerbils. Toxicology. 1981;21(2):105–115. [PubMed]
  • Kjellstrand, P; Holmquist, B; Alm, P; Kanje, M; Romare, S; Jonsson, I; Månsson, L; Bjerkemo, M. Trichloroethylene: further studies of the effects on body and organ weights and plasma butyrylcholinesterase activity in mice. Acta Pharmacol Toxicol (Copenh). 1983 Nov;53(5):375–384. [PubMed]
  • Kjellstrand, P; Holmquist, B; Mandahl, N; Bjerkemo, M. Effects of continuous trichloroethylene inhalation on different strains of mice. Acta Pharmacol Toxicol (Copenh). 1983 Nov;53(5):369–374. [PubMed]
  • Nakajima, T; Okino, T; Okuyama, S; Kaneko, T; Yonekura, I; Sato, A. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. Toxicol Appl Pharmacol. 1988 Jun 30;94(2):227–237. [PubMed]
  • Okino, T; Nakajima, T; Nakano, M. Morphological and biochemical analyses of trichloroethylene hepatotoxicity: differences in ethanol- and phenobarbital-pretreated rats. Toxicol Appl Pharmacol. 1991 May;108(3):379–389. [PubMed]
  • Barton, HA; Flemming, CD; Lipscomb, JC. Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology. 1996 Jul 17;111(1-3):271–287. [PubMed]
  • Clewell, HJ; Gentry, PR; Gearhart, JM; Allen, BC; Andersen, ME. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. Chemosphere. 1995 Jul;31(1):2561–2578. [PubMed]
  • Kodell, RL; West, RW. Upper confidence limits on excess risk for quantitative responses. Risk Anal. 1993 Apr;13(2):177–182. [PubMed]
  • Allen, BC; Kavlock, RJ; Kimmel, CA; Faustman, EM. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam Appl Toxicol. 1994 Nov;23(4):496–509. [PubMed]
  • Cresteil, T. Onset of xenobiotic metabolism in children: toxicological implications. Food Addit Contam. 1998;15 Suppl:45–51. [PubMed]
  • DeAngelo, AB; Daniel, FB; McMillan, L; Wernsing, P; Savage, RE., Jr Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol Appl Pharmacol. 1989 Nov;101(2):285–298. [PubMed]
  • Sanchez, IM; Bull, RJ. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology. 1990 Oct;64(1):33–46. [PubMed]
  • Larson, JL; Bull, RJ. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol. 1992 Aug;115(2):278–285. [PubMed]
  • Larson, JL; Bull, RJ. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol. 1992 Aug;115(2):268–277. [PubMed]
  • Styles, JA; Wyatt, I; Coutts, C. Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mouse. Carcinogenesis. 1991 Sep;12(9):1715–1719. [PubMed]
  • Ketcha, MM; Stevens, DK; Warren, DA; Bishop, CT; Brashear, WT. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J Anal Toxicol. 1996 20(4):236–241.Jul–Aug; [PubMed]
  • Goeptar, AR; Commandeur, JN; van Ommen, B; van Bladeren, PJ; Vermeulen, NP. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem Res Toxicol. 1995 8(1):3–21.Jan–Feb; [PubMed]
  • Breimer, DD. Clinical pharmacokinetics of hypnotics. Clin Pharmacokinet. 1977 2(2):93–109.Mar–Apr; [PubMed]
  • Stewart, RD; Dodd, HC; Gay, HH; Erley, DS. Experimental human exposure to trichloroethylene. Arch Environ Health. 1970 Jan;20(1):64–71. [PubMed]
  • Nomiyama, K; Nomiyama, H. Dose-response relationship for trichloroethylene in man. Int Arch Occup Environ Health. 1977 Sep 15;39(4):237–248. [PubMed]
  • Windemuller, FJ; Ettema, JH. Effects of combined exposure to trichloroethylene and alcohol on mental capacity. Int Arch Occup Environ Health. 1978 Mar 15;41(2):77–85. [PubMed]
  • Salvini, M; Binaschi, S; Riva, M. Evaluation of the psychophysiological functions in humans exposed to trichloroethylene. Br J Ind Med. 1971 Jul;28(3):293–295. [PubMed]
  • Konietzko, H; Elster, I; Bencsath, A; Drysch, K; Weichardt, H. EEG-Veränderungen unter definierter Trichloräthylen-Exposition. Int Arch Occup Environ Health. 1975 Sep 19;35(3-4):257–264. [PubMed]